The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations
- PMID: 26873090
- DOI: 10.1007/s40258-016-0225-6
The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations
Abstract
Background: Immunization rates for human papillomavirus (HPV) infections remain low among teenagers despite strong evidence of the effectiveness of vaccines. Physician recommendations of the vaccine are far from universal. Several states have enacted policies that mandate HPV vaccination or distribute educational materials.
Objectives: To provide policy makers, physicians, and researchers information on the relative importance of physician recommendations and early state-level policies to promote HPV vaccinations among targeted age groups.
Methods: We first use probit models to determine the strongest correlates of immunization in a nationally representative US sample of teenagers. We then use instrumental variable probit models to determine the direct role that physician recommendations play in vaccination using plausibly exogenous physician encounters that are likely not the result of more health-conscious parents seeking out information on the vaccine.
Results: We show that children in the targeted age range who are more likely to encounter physicians for reasons other than seeking out the vaccine, such as through mandatory wellness exams or previous asthma diagnoses, are significantly more likely to get the vaccine. There is no consistent evidence that the state policies we analyze have been effective.
Conclusion: Encouraging recommendations by physicians may be the most effective path toward increasing HPV vaccination. State-level mandates and policies are yet to exhibit effectiveness.
Similar articles
-
Early policy responses to the human papillomavirus vaccine in the United States, 2006-2010.J Adolesc Health. 2014 Nov;55(5):659-64. doi: 10.1016/j.jadohealth.2014.04.015. Epub 2014 Jun 10. J Adolesc Health. 2014. PMID: 24928803
-
Prevalence and predictors of human papillomavirus vaccination in adolescent girls.J Am Pharm Assoc (2003). 2012 Jan-Feb;52(1):52-8. doi: 10.1331/JAPhA.2012.10195. J Am Pharm Assoc (2003). 2012. PMID: 22257616
-
Recommend, but also Discuss: Different Patterns of Physician-Perceived Barriers to Discussing HPV Vaccination and Their Association with Vaccine Administration in 11-12 Year-Old Girls.Matern Child Health J. 2016 Dec;20(12):2539-2547. doi: 10.1007/s10995-016-2079-9. Matern Child Health J. 2016. PMID: 27473091
-
Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?Vaccine. 2013 Nov 12;31(47):5500-5. doi: 10.1016/j.vaccine.2013.09.031. Epub 2013 Oct 3. Vaccine. 2013. PMID: 24095883 Review.
-
Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease.Epidemiol Rev. 2006;28:88-100. doi: 10.1093/epirev/mxj006. Epub 2006 Jun 1. Epidemiol Rev. 2006. PMID: 16740585 Review.
Cited by
-
Impacts of the US CDC recommendation on human papillomavirus vaccine uptake, 2010-2015.Front Public Health. 2024 Dec 18;12:1464685. doi: 10.3389/fpubh.2024.1464685. eCollection 2024. Front Public Health. 2024. PMID: 39744345 Free PMC article.
-
The impact of school-entry mandates on social inequalities in human papillomavirus vaccination.SSM Popul Health. 2020 Aug 18;12:100647. doi: 10.1016/j.ssmph.2020.100647. eCollection 2020 Dec. SSM Popul Health. 2020. PMID: 33024808 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical